- Condition: Cardiovascular Disease
Interventions: Drug: Methotrexate; Drug: Placebo
Sponsors: Brigham and Women's Hospital; Brigham and Women's Hospital; National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified May 2012 - Condition: Ewing Family of Tumors, Rhabdomyosarcoma
Intervention: Drug: Lipegfilgrastim
Sponsors: Teva Pharmaceutical Industries; Merckle GmbH
Not yet recruiting - verified May 2012 - Condition: Adenovirus
Intervention:
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries; Department of Defense
Recruiting - verified April 2012 - Condition: Asthma
Interventions: Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4; Other: Placebo DPI; Drug: Flovent Diskus 250 mcg
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Not yet recruiting - verified May 2012 - Condition: Prostate Cancer
Interventions: Drug: cabazitaxel, prednisone, custirsen sodium; Drug: cabazitaxel, prednisone
Sponsors: OncoGenex Technologies; OncoGenex Technologies; Teva Pharmaceutical Industries
Not yet recruiting - verified April 2012 - Condition: Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Glatiramer Acetate; Drug: Matching placebo
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Recruiting - verified May 2012 - Condition: Metastatic Breast Cancer
Intervention:
Sponsors: Teva Pharma; Teva Pharma
Recruiting - verified May 2012 - Condition: Allergic Rhinitis
Interventions: Drug: BDP HFA Nasal Aerosol; Drug: BDP HFA Nasal Aerosol; Drug: BDP HFA Inhalation Aerosol (QVAR)
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Completed - verified February 2012 - Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Mometasone furoate; Drug: Nasonex®; Drug: Placebo
Sponsors: Teva Pharmaceuticals USA; Teva Pharmaceuticals USA
Completed - verified January 2012 - Condition: Multiple Sclerosis
Interventions: Drug: Glatiramer Acetate (GTR); Drug: Glatiramer Acetate (Copaxone®); Drug: Placebo
Sponsors: Synthon BV; Synthon BV
Recruiting - verified April 2012 - Condition: Parkinson's Disease
Interventions: Drug: Rasagiline/Placebo; Drug: Rasagiline
Sponsors: Georgetown University; Georgetown University; Teva Neuroscience, Inc.
Enrolling by invitation - verified October 2011 - Condition: Cancer
Intervention: Drug: Custirsen, paclitaxel and carboplatin
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries; OncoGenex Technologies
Active, not recruiting - verified May 2012 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Flovent Diskus; Drug: Fluticasone propionate DPI Dose 1; Drug: Fluticasone propionate DPI Dose 2; Drug: Fluticasone propionate DPI Dose 3; Drug: Fluticasone propionate DPI Dose 4
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries; PPD
Recruiting - verified May 2012 - Condition: Multiple Sclerosis
Intervention: Other: NA-NOSE artificial olfactory system
Sponsors: Carmel Medical Center; Carmel Medical Center; Technion, Israel Institute of Technology
Recruiting - verified March 2012 - Condition: Healthy
Interventions: Drug: Donepezil; Drug: Aricept®
Sponsors: Teva Pharmaceuticals USA; Teva Pharmaceuticals USA
Completed - verified September 2011 - Condition: Healthy
Interventions: Drug: Donepezil; Drug: Aricept®
Sponsors: Teva Pharmaceuticals USA; Teva Pharmaceuticals USA
Completed - verified September 2011 - Conditions: Sleep Disturbances; Parkinsons's Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: Dresden University of Technology; Dresden University of Technology; Teva Pharmaceutical Industries
Not yet recruiting - verified September 2011 - Condition: Crohn's Disease
Interventions: Drug: 80 mg Delayed Release 6 Mercaptopurine; Drug: 80 mg Delayed Release 6 Mercaptopurine
Sponsors: Teva GTC; Teva GTC
Not yet recruiting - verified September 2011 - Condition: Asthma
Interventions: Drug: Placebo; Drug: Albuterol dry powder
Sponsors: Teva Branded Pharmaceutical Products, R&D Inc.; Teva Branded Pharmaceutical Products, R&D Inc.
Terminated - verified August 2011 - Condition: Relapsing Remitting Multiple Sclerosis
Intervention:
Sponsors: University of Southern California; University of Southern California; Teva Pharmaceuticals USA
Recruiting - verified November 2011 - Condition: Multiple Sclerosis
Interventions: Drug: diclofenac sodium topical gel; Other: Placebo
Sponsors: Brown, Theodore R., M.D., MPH; Brown, Theodore R., M.D., MPH; Teva Neuroscience, Inc.
Recruiting - verified October 2011 - Condition: Healthy
Interventions: Drug: Trazodone; Drug: Quetiapine; Drug: Pindolol; Procedure: Blood Collection
Sponsors: University of Ottawa; University of Ottawa
Recruiting - verified July 2011 - Condition: Relapsing Multiple Sclerosis
Interventions: Drug: laquinimod; Drug: placebo
Sponsors: Teva Pharmaceutical Industries; Teva Pharmaceutical Industries
Suspended - verified December 2011 - Condition: Asthma
Interventions: Drug: extra fine particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhaler; Drug: standard particle particle hydrofluoroalkane beclomethasone dipropionate via metered dose inhaler
Sponsors: Research in Real-Life Ltd; Research in Real-Life Ltd; Teva Pharmaceutical Industries
Completed - verified July 2011 - Condition: Celiac Disease
Interventions: Drug: Larazotide Acetate 0.5 mg; Drug: Larazotide Acetate 1 mg; Drug: Larazotide Acetate 2 mg; Drug: placebo
Sponsors: Alba Therapeutics; Alba Therapeutics; Teva Pharmaceuticals USA
Recruiting - verified July 2011 - Conditions: Hemostasis; Oral Contraceptive
Interventions: Drug: Desogestrel/ethinyl estradiol and ethinyl estradiol; Drug: Desogestrel/ethinyl estradiol
Sponsors: Teva Women's Health; Teva Women's Health
Active, not recruiting - verified March 2012 - Condition: Chronic Hepatitis
Intervention: Drug: Peginterferon alpha-2a + Ribavirin
Sponsors: Casa Sollievo della Sofferenza IRCCS; Casa Sollievo della Sofferenza IRCCS; Casa di Cura Mater Dei; IRCCS L. Spallanzani; Ospedale Francesco Ferrari, Casarano; Ospedale SS. Annunziata, Sassari; IRCCS Policlinico S. Matteo; Arcispedale S. Anna, Ferrara; Azienda Ospedaliero-Universitaria, Catania; Ospedale di Venosa; Ospedale R. Dimiccoli, Barletta; IRCCS De Bellis, Castellana; USL Napoli 1; Ospedale San Giuseppe Moscati, Avellino; Cardarelli Hospital; Ospedale Civile Vittorio Emanuele II, Bisceglie; Azienda Ospedaliero-Universitaria Careggi; Azienda Ospedaliera V. Cervello; Ospedale Civile Spirito Santo; Ospedale di Canosa di Puglia; University of Palermo; San Camillo Hospital, Rome; Campus Bio-Medico University; Ospedale Sandro Pertini, Roma; Ospedali Riuniti, Foggia; Ospedale SS. Annunziata, Taranto; Ospedale di Mottola; Ospedale Santa Caterina Novella, Galatina; University of Florence; Ospedale Valduce, Como; University of Bari; Azienda Ospedaliera, Siracusa; Azienda Ospedaliera, Lucca
Recruiting - verified April 2012 - Condition: Parkinson's Disease
Interventions: Drug: Rasagiline; Drug: Placebo
Sponsors: Brown University; Brown University; Teva Pharmaceuticals USA
Recruiting - verified June 2011
 |
Teva Pharma - Database of Clinical Trials by Pharmaceutical Companies |
